BioSpace News Archive

Baze, one of America’s leading evidence-based personalized nutrition companies, today announced approval from the Food and Drug Administration for its at-home blood collection process.

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today the addition of Dr. Alexander Fleming to its Scientific Advisory Board.

Genome Medical, a leader in telegenomics-based clinical care, today announced that it has expanded its services to enable collaborative population genomics programs with health systems across the country.

Incyte announced that it has scheduled its fourth quarter and year-end 2019 financial results conference call and webcast for 8:00 a.m. ET on Thursday, February 13, 2020.

Certara®, the global model-informed drug development and decision support leader, today reported that more than 90% of novel new drug approvals by the US Food and Drug Administration (FDA) in 2019 were supported by Certara software or consulting services

Assistance Publique – Hôpitaux de Paris (AP-HP), Europe’s leading clinical research center, joins IQVIA™, the global health technology and human data science company, to launch the Paris Prime Site for clinical trials

PathoQuest, a company with expertise in genomic analysis, announced today that it has received GLP certificate of conformity following a successful inspection by the French National Agency for Medicine and Health Products Safety (ANSM).

Risdiplam demonstrated statistically significant and medically meaningful motor milestone improvement in infants with Type 1 SMA

Cigna’s 2020 Loneliness Index reveals three in five Americans consider themselves lonely and highlights the business impact of loneliness

Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that it has completed principle design work for a PCR screening test for new coronavirus, 2019-nCoV, intended to address potential need for detection of the virus.